Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2020 | Alzheimer’s disease diagnosis: blood spectroscopy in the clinical setting

Mary Paraskevaidi • 27 Apr 2020
ARUK 2020
Alzheimer’s Disease Dementia

Mary Paraskevaidi, PhD, University of Central Lancashire, Lancashire, UK, and Imperial College London, London, UK, discusses how blood spectroscopy can be translated from a laboratory-based tool to a useful clinical tool. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

More from Mary Paraskevaidi

4:00
Benefits of early detection in Alzheimer's disease
Mary Paraskevaidi • 27 Apr 2020
2:59
Spectroscopic techniques for non-invasive diagnosis of Alzheimer’s disease
Mary Paraskevaidi • 27 Apr 2020
2:00
The role of blood spectroscopy in the Alzheimer's disease diagnostic process
Mary Paraskevaidi • 27 Apr 2020
1:44
Alzheimer's disease outlook: sensitive diagnostic approaches & efficient treatments
Mary Paraskevaidi • 27 Apr 2020

Related Videos

3:58
Promising FONLISA test for ultrasensitive detection of plasma NfL in Alzheimer’s disease
Madison Honey • 7 Mar 2024
4:12
Updates in Alzheimer’s treatment: the potential of NSC001
Manfred Windisch • 6 Mar 2024
4:44
Influence of genetic risk for psychiatric disorders on dementia
Jenna Najar • 6 Mar 2024
2:31
Barriers to dementia treatment: awareness, accessibility, and affordability
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals